Skip to content

Defense-News.io: The Tank Is Dead – A 2030 Battlefield Autopsy

(defense-news.io) By 2030, the main battle tank (MBT)—once the undisputed king of land warfare—will be a museum piece, not a frontline asset. Three converging revolutions have sealed its fate: Below is the forensic evidence, drawn from Nagorno-Karabakh (2020), Ukraine (2022–2025), and the U.S. Army’s own panic pivot. 1. The Roof Is the New Front Door 2. […]

The Tank Is Dead: A 2030 Battlefield Autopsy
author avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
See Full Bio
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu

Similar Posts

CDC Revises Website: No Evidence Against Vaccine-Autism Link – Scientists Warn of Misinformation

The U.S. Centers for Disease Control and Prevention (CDC) fundamentally changed its vaccine safety website on November 19, 2025. The previous clear statement…

more »CDC Revises Website: No Evidence Against Vaccine-Autism Link – Scientists Warn of Misinformation

Pharma Giants Strengthen US Production: Novartis and Moderna Invest Billions in New Facilities

Amid increasing uncertainties due to possible tariffs and trade conflicts, large pharmaceutical companies are focusing on stronger anchoring in the USA. Novartis and Moderna have recently made extensive 

more »Pharma giants strengthen US production: Novartis and Moderna invest billions in new facilities

Skin-permeable polymer enables needle-free insulin delivery through the skin

A newly developed polymer can penetrate intact skin and deliver large molecules such as insulin into the bloodstream without a syringe or microneedles. Chinese researchers report in 

more »Skin-permeable polymer enables needle-free insulin delivery through the skin